Literature DB >> 11731407

Suppression of intestinal polyposis in Apc(Min/+) mice by inhibiting nitric oxide production.

B Ahn1, H Ohshima.   

Abstract

Inducible nitric oxide synthase (iNOS) was shown to be expressed in normal mucosa and adenoma of small and large intestines of Apc(Min/+) mice by reverse transcription-PCR and immunohistochemistry. Administration of the iNOS inhibitor aminoguanidine (1.5 g/liter) in drinking water or an L-arginine-deficient diet to Apc(Min/+) mice resulted in a significant decrease in adenoma development in the small but not the large intestine. Similarly, iNOS-gene knockout Apc(Min/+) mice (Apc(Min/+) iNOS(-/-) or Apc(Min/+) iNOS(-/+)) developed significantly fewer adenomas in both small and large intestines than Apc(Min/+) iNOS(+/+) mice. These results suggest that iNOS-selective inhibitors could be used as a potential chemopreventive agent for colorectal cancers.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11731407

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  33 in total

Review 1.  Nitric oxide and cancer therapy: the emperor has NO clothes.

Authors:  Jason R Hickok; Douglas D Thomas
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

2.  Effect of a nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester on invasion of human colorectal cancer cell line SL-174T.

Authors:  Li-Bo Yu; Xin-Shu Dong; Wen-Zhou Sun; Dong-Lu Zhao; Yue Yang
Journal:  World J Gastroenterol       Date:  2005-10-28       Impact factor: 5.742

3.  Anti-cancer activity of nitrones in the Apc(Min/+) model of colorectal cancer.

Authors:  Robert A Floyd; Rheal A Towner; Dee Wu; Andrew Abbott; Rebecca Cranford; Dan Branch; Wei-Xing Guo; Steven B Foster; Inna Jones; Rajib Alam; Danny Moore; Toby Allen; Mark Huycke
Journal:  Free Radic Res       Date:  2010-01

4.  Colorectal carcinoma development in inducible nitric oxide synthase-deficient mice with dextran sulfate sodium-induced ulcerative colitis.

Authors:  Darren N Seril; Jie Liao; Guang-Yu Yang
Journal:  Mol Carcinog       Date:  2007-05       Impact factor: 4.784

Review 5.  Interplay between DNA repair and inflammation, and the link to cancer.

Authors:  Dawit Kidane; Wook Jin Chae; Jennifer Czochor; Kristin A Eckert; Peter M Glazer; Alfred L M Bothwell; Joann B Sweasy
Journal:  Crit Rev Biochem Mol Biol       Date:  2014-01-13       Impact factor: 8.250

Review 6.  Metabolic mechanisms of tumor resistance to T cell effector function.

Authors:  Candace M Cham; Thomas F Gajewski
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

7.  Silibinin suppresses spontaneous tumorigenesis in APC min/+ mouse model by modulating beta-catenin pathway.

Authors:  Subapriya Rajamanickam; Manjinder Kaur; Balaiya Velmurugan; Rana P Singh; Rajesh Agarwal
Journal:  Pharm Res       Date:  2009-09-25       Impact factor: 4.200

8.  Expression of inducible nitric oxide synthase is increased in rat Barrett's esophagus induced by duodenal contents reflux.

Authors:  Jong Dae Bae; Ki Hoon Jung; Woo Sup Ahn; Sung Han Bae; Tae Jung Jang
Journal:  J Korean Med Sci       Date:  2005-02       Impact factor: 2.153

9.  Chemoprevention of Colon Cancer by iNOS-Selective Inhibitors.

Authors:  Naveena B Janakiram; Chinthalapally V Rao
Journal:  For Immunopathol Dis Therap       Date:  2012-01-01

10.  The Ron receptor tyrosine kinase is not required for adenoma formation in Apc(Min/+) mice.

Authors:  Sara E Meyer; Susan E Waltz; Kathleen H Goss
Journal:  Mol Carcinog       Date:  2009-11       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.